| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |